The cases of monkeypox they keep increasing. Although there is no specific treatment for this virus, there are several medical options that help those infected recover.
medication
The Food and drug administration approved TPOXXalso known as tecovirimatfor the treatment of smallpox in 2018. It did so for adults and children based on studies of animals infected with monkeypox and rabbit pox, as well as in healthy people.
Studies in animals given lethal doses of monkeypox found that treatment with Tecovirimat for 14 days significantly increased survival rates. When treatment was started four or five days after infection, between 80 and 100% of treated animals survived. None of the animals in the placebo groups survived.
The antiviral has been approved by the European Union through a mechanism that allows approval of “exceptional circumstances”. Although TPOXX has only been tested on healthy people, the European Medicines Agency He said the effects should be similar in infected people. Consider that the benefits of the antiviral outweigh its risks.
The National Health Service (NHS) from the UK states that “the illness is usually mild and the majority of those infected recover within weeks without treatment”. Therefore, this type of treatment is recommended for those who develop more serious disease.
Health authorities recommend that mild patients maintain a quarantine at rest without maintaining contact with other people to avoid new infections. This quarantine, once the case is diagnosed, should last a few 21 days.
Vaccines
There is no specific vaccine against the virus. monkeypox. But due to its genetic similarity to smallpox, several countries use antiviral drugs and vaccines that have been developed to protect against it.
As indicated by the Centers for Disease Control (CDC) of the United States, “when given appropriately before or after recent exposure (to the virus), vaccines can be effective tools in protecting people against monkeypox disease.”
In the United States, United Kingdom, Europe and other countries, the use of the JYNNEOS vaccine (also known as Imvamune or Imvanex), for monkeypox infection.